SCHEMBL7974162

SCHEMBL7974162

CCC(=O)Nc1ncn(Cc2cccc(Cl)c2)c1C(N)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.52
YTHDC1 Q96MU7 3/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
GLA P06280 1/20 0.45
HTT P42858 1/20 0.45
UBE2N P61088 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ADRA1D P25100 1/20 0.45
MAPT P10636 3/20 0.43
TP53 P04637 2/20 0.43
FGFR1 P11362 1/20 0.41
FGFR4 P22455 1/20 0.41
ALDH1A1 P00352 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
EGLN1 Q9GZT9 1/20 0.41
ACP1 P24666 1/20 0.41
KMT2A Q03164 1/20 0.41
MMP13 P45452 1/20 0.40
POLB P06746 1/20 0.40
PLA2G1B P04054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988379 0.92 KDM4E (0.50) KDM4EYTHDC1L3MBTL1GLAHTT
SCHEMBL7991565 0.89 TSHR (0.49) KDM4EYTHDC1L3MBTL1GLAHTT
SCHEMBL7987961 0.88 MAPT (0.47) YTHDC1ADRA1DMAPTTP53ALDH1A1
SCHEMBL7985670 0.87 CDK9 (0.42) KDM4EYTHDC1L3MBTL1MAPTALDH1A1
SCHEMBL7992368 0.85 TP53 (0.47) YTHDC1ADRA1DMAPTTP53RXFP1
SCHEMBL7986281 0.85 KMT2A (0.39) KDM4EYTHDC1MAPTFGFR1FGFR4
SCHEMBL7974040 0.84 KDM4E (0.51) KDM4EYTHDC1ADRA1DALDH1A1
SCHEMBL7973987 0.83 FGFR1 (0.45) HTTSMN1; SMN2MAPTFGFR1FGFR4
SCHEMBL7987598 0.83 RIOK2 (0.41) KDM4EYTHDC1L3MBTL1SMN1; SMN2FGFR1
SCHEMBL7988641 0.82 KMT2A (0.44) KDM4ESMN1; SMN2MAPTFGFR1FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed